CVS HEALTH Corp — Director's Dealing 2021

Apr 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2021-02-01

Reporting Person: Boratto Eva C (EVP & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-01	Common Stock	A	88500	—	Acquired	159582.0445	Direct
2021-04-01	Common Stock	F	40128	$74.30	Disposed	119454.0445	Direct
2021-04-01	Common Stock	F	649	$74.30	Disposed	120236.0445	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-01	Stock Option	$74.30	A	103663	Acquired	2031-04-01	Common Stock (103663)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock (restricted)	2242	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option	$102.26	2022-04-01	Common Stock (27392)	27392	Direct
Stock Option	$104.82	2023-04-01	Common Stock (21509)	21509	Direct
Stock Option	$78.05	2024-04-03	Common Stock (35062)	35062	Direct
Stock Option	$62.21	2025-04-01	Common Stock (35030)	35030	Direct
Stock Option	$54.19	2029-04-01	Common Stock (202007)	202007	Direct
Stock Option	$58.34	2030-04-01	Common Stock (168956)	168956	Direct

Footnotes

F1: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on February 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 1, 2021. The PSUs vested and settled on April 1, 2021.

F2: Surrender of shares in payment of taxes due upon the vesting and settlement of the PSUs on April 1, 2021.

F3: Surrender of shares in payment of taxes due upon the vesting and settlement of a restricted stock unit award on April 1, 2021.

F4: Option becomes exercisable in four equal annual installments, commencing 4/1/2022.

F5: Option became exercisable in four equal annual installments, commencing 4/1/2016.

F6: Option becomes exercisable in four equal annual installments, commencing 4/1/2017.

F7: Option became exercisable in four equal annual installments, commencing 4/3/2018.

F8: Option became exercisable in four equal annual installments, commencing 4/1/2019.

F9: Option became exercisable in four equal annual installments, commencing 4/1/2020.

F10: The number of shares subject to the option were calculated using a 30-day average price.

F11: Options became exercisable in four equal annual installments, commencing 4/1/2021.